What telmisartan dose is equivalent to lisinopril 40 mg for hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Telmisartan 80 mg is the equivalent dose to lisinopril 40 mg for hypertension management.

Dose Equivalency Based on Guidelines

The 2020 ACC/AHA Heart Failure Guidelines provide clear target dosing tables showing that lisinopril 20 mg once daily is the target dose for heart failure, while telmisartan 80 mg once daily is the target dose for ARBs 1. When lisinopril is used at 40 mg (double the guideline target of 20 mg), the equivalent telmisartan dose would be 80 mg once daily, which represents the maximum evidence-based target dose for this ARB.

The 2022 AHA/ACC/HFSA Heart Failure Guidelines similarly list lisinopril target doses of 20-40 mg daily and telmisartan 80 mg once daily as the target dose 2. The FDA-approved dosing for telmisartan confirms that the therapeutic range is 20-80 mg, with 80 mg being the maximum recommended dose for both hypertension and cardiovascular risk reduction 3.

Clinical Evidence Supporting This Equivalency

Direct comparative trials demonstrate that telmisartan 80 mg provides superior or equivalent blood pressure control compared to lisinopril 40 mg 4. In a 52-week randomized trial of 578 patients with mild-to-moderate hypertension, telmisartan (titrated up to 160 mg) and lisinopril (titrated up to 40 mg) achieved similar DBP control rates (83% vs 87%) with blood pressure reductions of 23.8/16.6 mmHg for telmisartan versus 19.9/15.6 mmHg for lisinopril 4.

Another comparative study showed telmisartan 80 mg was associated with significantly greater mean decreases in trough systolic and diastolic blood pressure than enalapril 20 mg (p<0.05), and provided similar efficacy to lisinopril across the dose ranges studied 5.

Practical Dosing Algorithm

For switching from lisinopril 40 mg to telmisartan:

  • Start telmisartan 80 mg once daily (the maximum target dose)
  • Monitor blood pressure within 2 weeks (most antihypertensive effect apparent by this time) 3
  • Maximal blood pressure reduction typically achieved by 4 weeks 3
  • If blood pressure remains uncontrolled, add hydrochlorothiazide rather than exceeding telmisartan 80 mg 6, 7

Important Clinical Considerations

Telmisartan offers specific advantages over lisinopril:

  • Significantly lower incidence of treatment-related cough (3% vs 7%, p=0.018) 4
  • Lower discontinuation rate due to cough (0.3% vs 3.1%, p=0.007) 4
  • Longer half-life providing more sustained 24-hour blood pressure control 5, 8
  • Better tolerability profile overall (28% vs 40% treatment-related side effects, p=0.001) 4

Critical safety note: Do not combine telmisartan with ACE inhibitors like lisinopril. The ONTARGET trial demonstrated that dual RAS blockade with telmisartan 80 mg plus ramipril 10 mg increased adverse events (syncope, renal impairment, dialysis requirement) without additional cardiovascular benefit 9. This combination is explicitly not recommended by current guidelines 1, 6, 7.

For patients with chronic kidney disease or those on potassium-sparing medications, monitor serum potassium and renal function closely when initiating telmisartan 80 mg 10, 6, 11.

References

5
Research

Comparative effects of telmisartan in the treatment of hypertension.

Journal of clinical hypertension (Greenwich, Conn.), 2002

Related Questions

For an elderly patient with hypertension, what are the maximal doses of lercanidipine and telmisartan, and what is the third most appropriate antihypertensive agent to add?
Can telmisartan be given in a twice (bd) daily dose?
How should I evaluate and manage a 52-year-old female (BMI ~34.6 kg/m²) with hypertension on telmisartan 40 mg daily and amlodipine 5 mg daily, presenting with a 2‑day history of generalized body aches, normal vital signs, normal TSH, normal serum calcium, normal uric acid, mild anemia (hemoglobin 11 g/dL) and HbA1c 5.2 %?
How should I evaluate and manage a 65-year-old female with hypertension on telmisartan 40 mg/amlodipine 5 mg daily who presents with a one‑week history of bilateral calcaneal pain and tenderness?
What are the downsides of taking telmisartan (angiotensin II receptor antagonist) twice daily instead of once daily?
What are the dosing guidelines, contraindications, and monitoring recommendations for nortriptyline in adults?
How should a patient with a serum vitamin B12 level of 169 pg/mL be treated?
What does increasing vibration sensation in a ceramic dental implant without pain, especially when jumping or experiencing external vibrations, indicate?
What is the recommended prednisone dosing schedule (4 mg per kilogram per day) for a four‑day course, including any taper if needed?
In a patient taking amitriptyline 25 mg and guanfacine 1 mg, how should I safely taper off amitriptyline after initiating guanfacine to minimize hepatic risk given abnormal liver function tests?
Is feeling vibration through a well‑integrated ceramic dental implant several years after placement considered normal if it is painless and the implant remains stable?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.